stockrow
Saturday 7 November 2026
Export FTH’s income statement to Excel — free account
Faeth Therapeutics, Inc.
- EPS
- +78.2%
- Free cash flow
- −262.7%
Quarter to September 2026, against a year earlier
21.86
1.94
+9.74%
Follow FTH
Alert me
| Sep '26 | Jun '26 | Mar '26 | Dec '25 | Older periods | |
|---|---|---|---|---|---|
Current Ratio |
16.12 | 19.69 | 14.39 | 5.06 |
+8 more quarters Free account |
Net Debt/EBITDA |
7.92 | 10.15 | 1.19 | 4.30 | |
Debt/Assets |
0.00% | 0.00% | 0.00% | 0.00% | |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.00 | |
Asset Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
0.64 | 0.98 | 0.06 | 0.82 | |
Capex/Depreciation |
(0.18) | 0.00 | (0.20) | 0.00 | |
Interest Coverage |
— | — | — | (190.65) | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Free Cash Flow per Share |
(0.50) | (2.78) | (8.29) | (3.06) | |
Cash per Share |
6.76 | 33.04 | 156.58 | 16.80 | |
Shareholders Equity per Share |
6.23 | 30.65 | (106.00) | 14.74 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
6.23 | 30.65 | (106.00) | 14.74 | |
Free Cash Flow |
(13.00) | (15.67) | (10.74) | (3.86) | |
Working Capital |
166.81 | 179.08 | 190.04 | 17.26 | |
Capital Expenditures |
0.00 | 0.00 | (0.01) | 0.00 | |
Net Current Asset Value |
159.99 | 172.31 | (138.43) | 17.20 | |
| Other line items | |||||
Quick Ratio |
15.84 | 19.46 | 14.29 | 4.98 | |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF per Share |
(0.50) | (2.78) | (8.29) | (3.06) | |
Capex per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Average Payables |
5.02 | 4.35 | 5.67 | 1.36 | |
Average Assets |
103.27 | 110.54 | 121.83 | 34.13 | |
Average Common Equity |
92.05 | 100.14 | (52.65) | 28.49 | |
Capex to Sales |
0.00 | 0.00 | 0.00 | 0.00 |
Columns are period end dates · fundamentals updated 5 Nov 2026